WEDNESDAY, NOVEMBER 22, 2017

Younger doctors less likely to believe vaccines effective

A study presented on Thursday at a meeting of the Infectious Diseases Society of America reported that younger doctors are less likely than their older peers to believe in the absolute effectiveness and safety of vaccines. Read More »

Gates affirms commitment to eradicating malaria

In an interview with Reuters at his Gates Foundation's Malaria Forum in Seattle, billionaire philanthropist Bill Gates rejected skepticism his goal of wiping out the killer mosquito-borne malaria worldwide. Read More »

Canadian measles outbreak continues unabated

A measles outbreak in Canada continues unabated in both the immunized and unimmunized population, raising questions about the effectiveness of the nation Read More »

Genetic variants linked to dengue fever susceptibility

A new study has identified two genetic variants linked with an increased susceptibility to severe dengue fever. Read More »

FDA warns of needle-free flu shots

The Food and Drug Administration recently warned doctors, nurses and pharmacists about the painless, needle-free shots that many pharmacies are offering for the first time because they have yet to be FDA-approved. Read More »

Flu vaccine does not carry miscarriage risks, experts say

According to several studies presented as the 49th annual meeting of the Infectious Disease Society of America's Pandemic Influenza Task Force, the flu vaccine does not raise the risk of miscarriage in pregnant women. Read More »

Cholera cases in Haiti this year may top 500,000

According to projections by the World Health Organization, the number of cholera cases in Haiti may reach 500,000 by the end of the year. Read More »

Utah measles outbreak cost $300,000

According to research presented at the annual meeting of the Infectious Diseases Society of America, a small outbreak of measles in Utah ended up costing local and state coffers approximately $300,000. Read More »

Three-dimensional measles model aids in life cycle understanding

Scientists studying measles have developed a new three-dimensional model of the virus that helps explain some unaccounted for observations in its life cycle. Read More »

West Nile virus spread linked to specific bird species

The spread of the West Nile virus in North America has been found to be related to only a few key species of bird hosts. Read More »

Earliest malaria parasite form can lay dormant and recover, research shows

A recent study showed that the earliest form of malaria parasites can lay dormant in red blood cells and recover after treatment with the antimalarial drug artesunate. Read More »

Eli Lilly to spend $30 million fighting TB

Pharmaceutical giant Eli Lilly & Co. intends to spend $30 million over the next five years to ensure that patients with drug-resistant tuberculosis have access to proper treatments. Read More »

Flu vaccine shows lower efficacy than thought

According to a meta-analysis conducted by researchers at the University of Minnesota, the trivalent inactivated influenza vaccine had a pooled efficacy of 59 percent in people 18 through 64. Read More »

Whooping cough outbreak at Illinois high school

Twenty-two students at the northwest suburban Cary-Grove High School in McHenry County, Ill., have been diagnosed with whooping cough, which comes more than a week after nine students contracted the illness. Read More »

Malaria No More names new CEO

Malaria No More, a non-government organization determined to end malaria deaths in Africa, appointed Dr. David Bowen as its new chief executive officer starting November 28. Read More »

New venture aims to speed the development of vaccines for neglected tropical diseases

The United Nations World Intellectual Property Organization and the non-profit BIO Ventures for Global Health have teamed up to speed up the royalty-free development of drugs, vaccines and diagnostics to treat neglected tropical diseases, tuberculosis and Read More »

Obese at greater risk for flu after vaccination

New findings suggest that the overweight and obese may be at a greater risk for catching the flu even if they are vaccinated. Read More »

Universal flu vaccine predicted by 2014

A universal influenza vaccine could be available by 2014 if a group of scientists are successful in their attempts and it is approved by the U.S. Food and Drug Administration. Read More »

ACIP recommends hepatitis B vaccination for adults with diabetes

The Advisory Committee on Immunization Practices voted on Tuesday to recommend vaccination against hepatitis B for adults with diabetes under the age of 60 and said that people older than 60 may get the vaccine. Read More »

Prevnar 13 approved for adults over 50 in Europe

Pfizer Inc.'s vaccine against dangerous bacterial infections has been approved in Europe for use in adults age 50 and older, the drugmaker announced on Thursday. Read More »